BioMarin Pharmaceutical Inc. reaffirmed earnings guidance for the year 2024. For the year, the company expects there is no change in total revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.43 USD | -1.44% | -3.76% | -22.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 14.34B | |
-2.30% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B | |
-13.92% | 7.53B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- Biomarin Pharmaceutical Inc. Reaffirms Earnings Guidance for the Year 2024